{"entity":{"id":"nct07337876","kind":"trial","name":"Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy","aka":[],"tldr":"A phase 2 trial of MR-guided adaptive radiotherapy in Rectal cancer, run by University Hospital Tuebingen, now recruiting.","summary":"Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy is a phase 2 interventional study registered as NCT07337876 by University Hospital Tuebingen, with 100 participants planned, started 2026-01-07 and due to reach its primary completion in 2029-01. Interventions recorded: Dose escalated radiotherapy using a 1.5 T MR-Linac. Conditions recorded: Rectal Cancer.\n\nLinked to the technology MR-guided adaptive radiotherapy because the registry's title names it (\"mr guided adaptive radiotherapy\") and Rectal cancer among its conditions. Registry record only: no result has been read by an editor.","status":"recruiting","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT07337876","url":"https://clinicaltrials.gov/study/NCT07337876"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["rectal-cancer"],"sections":[],"technologies":["mr-linac"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07337876","phase":"2","setting":"Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy","sponsor":"University Hospital Tuebingen","enrolled":100,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07337876/","neighbours":{"cancer":[{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"technology":[{"id":"mr-linac","kind":"technology","name":"MR-guided adaptive radiotherapy","route":"/technologies/mr-linac/"}]}}